Clin2
NCT07077811Possibly a fitEnrolling by invitation

Pulsed field ablation for heart failure with preserved pumping strength

Cardiovascular DiseasesHeart FailureAtrial Fibrillation (AF)HFpEF - Heart Failure With Preserved Ejection Fraction

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests a new procedure called pulsed field ablation for people who have both persistent atrial fibrillation and a type of heart failure (HFpEF). It aims to see if this ablation safely helps control the heart rhythm.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
158 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You have atrial fibrillation that does not come and go on its own (persistent AFib).
  • You have heart failure with preserved ejection fraction (HFpEF) confirmed by symptoms and test results.
  • You have not had atrial fibrillation for more than 3 years.
  • Your left atrium is not too large (less than 50 mm on echo).
  • You have not had prior heart surgery or ablation on the left side of your heart.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06739512Not yet recruiting
Pulsed field ablation for persistent atrial fibrillation

This trial tests a new procedure called pulsed field ablation to treat persistent atrial fibrillation (long-lasting irregular heartbeat). It compares different ways of using the procedure and may be an option if heart rhythm medicines haven't worked for you.

Shanghai, Shanghai Municipality
NCT06125925Recruiting
Ablation for AFib in patients with heart failure and preserved ejection fraction

This study tests whether a catheter ablation procedure can help people with atrial fibrillation and a kind of heart failure where the heart pumps normally but doesn't relax properly (HFpEF). It looks at whether the procedure can improve symptoms and heart function.

Nanjing
NCT07601763Recruiting
Pulsed Field Ablation for Atrial Fibrillation Treatment

This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.

Beijing, Beijing Municipality
NCT06801392Recruiting
Pulsed-field ablation for non-paroxysmal atrial fibrillation

This trial tests a new way to treat non-paroxysmal atrial fibrillation (AF) using a focused type of ablation (pulsed-field energy) on specific areas of the heart. It aims to see if targeting the left atrial wall and mitral isthmus can improve outcomes for people who have not had this procedure before.

Prague
NCT06803238Not yet recruiting
Pulsed-field ablation for persistent atrial fibrillation

This study tests a new type of energy (pulsed-field ablation) to create a lasting block in a specific area of the heart, aiming to improve the success of a procedure for people with persistent atrial fibrillation.

NCT07385417Recruiting
Early AF treatment for heart failure with preserved pumping function

This study tests using a new electrical pulse treatment for atrial fibrillation (AF) early on, in people who also have a type of heart failure where the heart pumps normally but is stiff. The goal is to see if this treatment helps manage both conditions better.

Frankfurt am Main

Hear when a new Cardiovascular Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.